Most Popular

Apple Inc.: Analyst Daniel Ives Provides Update From Inside The WWDC 2015

FBR Capital analyst Daniel Ives is out today with an update on Apple Inc. (NASDAQ:AAPL), straight from the annual WWDC Conference.

Roth Capital Reiterates Buy on Vical Incorporated Ahead of Upcoming HSV-2 Data Release

Roth Capital analyst Debjit Chattopadhyay came out with a research note on Vical Incorporated (NASDAQ:VICL), as the company is expected to release top-line …

Roth Capital Maintains Buy on Sarepta Therapeutics Inc as DMD-Sector Heating Up

In a research report released Sunday, Roth Capital analyst Debjit Chattopadhyay maintained a Buy rating on Sarepta Therapeutics Inc. (NASDAQ:SRPT) with a price …

Robert W. Baird Boosts Price Target for Tesla Motors Inc (TSLA) Ahead of Likely Catalysts

Robert W. Baird analyst Ben Kallo came out with a research report today on Tesla Motors Inc (NASDAQ:TSLA), reiterating an Outperform rating on and raising …

Monday Morning Pre-Market Insights: MannKind Corporation (MNKD), Seadrill Ltd (SDRL), Receptos Inc (RCPT), Plasmatech Biopharmaceuticals Inc (PTBI)

MannKind Corporation (NASDAQ:MNKD) shares increased more than 2% in pre-market trading to $6.25 after Shaunak Deepak, an analyst at Jefferies, reiterated a Buy …

Analysts Look For Updates on Apple Inc. (AAPL) Watch and iPhone

Since Apple Inc (NASDAQ: AAPL) became the highest valued company in the world with a $741.16 million market cap, analysts and investors have …

Canaccord Raises Price Target for Palatin Technologies, Inc. on Back of FDA AdCom Recommendation to Approve Flibanserin

Ahead of the bell, Palatin Technologies, Inc. (NYSEMKT:PTN) shares have popped 51%, following today’s news that the FDA advisory committee voted 18-6 in …

Maxim Group Shines Light on bluebird bio Inc (BLUE) and Celgene Corporation (CELG) Partnership Amendments

Maxim Group analyst Jason McCarthy weighed in today with a few insights on bluebird bio Inc (NASDAQ:BLUE), after the company made amendments on its …

Wedbush Highlights Upcoming Catalysts in the Pharmaceutical Sector: Intercept Pharmaceuticals Inc, Receptos Inc, Omeros Corporation

On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Receptos …

Synthetic Biologics Inc (SYN) Continues To Remain Undervalued: H.C. Wainwright

In a research report released today, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts